304
Views
40
CrossRef citations to date
0
Altmetric
Research Article

Serotonin 2c receptor RNA editing in major depression and suicide

, , , &
Pages 590-601 | Received 25 May 2011, Accepted 27 Sep 2011, Published online: 09 Mar 2012

References

  • Abbas AI, Urban DJ, Jensen NH, Farrell MS, Kroeze WK, Mieczkowski P, et al. 2005. Assessing serotonin receptor mRNA editing frequency by a novel ultra high-throughput sequencing method. Nucleic Acids Res 38:e118.
  • Akbarian S. 2008. Approaching the molecular pathology of suicide. Biol Psychiatry 64:643–644.
  • Bagdy G, Graf M, Anheuer ZE, Modos EA, Kantor S. 2001. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 4:399–408.
  • Bass BL. 2002. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 71:817–846.
  • Berg KA, Cropper JD, Niswender CM, Sanders-Bush E, Emeson RB, Clarke WP. 2001. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br J Pharmacol 134:386–392.
  • Boldrini M, Underwood MD, Hen R, Rosoklija GB, Dwork AJ, John MJ, et al. 2005. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 34:2376–2389.
  • Bristow LJ, O'Connor D, Watts R, Duxon MS, Hutson PH. 2000. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat. Neuropharmacology 39:1222–1236.
  • Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, et al. 2005. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387: 303–308.
  • Canton H, Emeson RB, Barker EL, Backstrom JR, Lu JT, Chang MS, et al. 2005. Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing. Mol Pharmacol 50:799–807.
  • Cavanagh JT, Carson AJ, Sharpe M, Lawrie SM. 2003. Psychological autopsy studies of suicide: a systematic review. Psychol Med 33:395–405.
  • Chanrion B, Mannoury la CC, Gavarini S, Seimandi M, Vincent L, Pujol JF, et al. 2005. Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction. Mol Pharmacol 73:748–757.
  • Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. 2001. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50:260–265.
  • Di Giovanni G, De Deurwaerdere P, Di Mascio M, Di MV, Esposito E, Spampinato U. 1999. Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91:587–597.
  • Di M, V, Cacchio M, Di GC, Di GG, Esposito E. 2002. Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo. Pharmacol Biochem Behav 71:607–613.
  • Dracheva S, Lyddon R, Barley K, Marcus SM, Hurd YL, Byne WM. 2009. Editing of serotonin 2C receptor mRNA in the prefrontal cortex characterizes high-novelty locomotor response behavioral trait. Neuropsychopharmacology 34:2237–2251.
  • Dracheva S, Patel N, Woo DA, Marcus SM, Siever LJ, Haroutunian V. 2008. Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide. Mol Psychiatry 13:1001–1010.
  • Du Y, Davisson MT, Kafadar K, Gardiner K. 2006. A-to-I pre-mRNA editing of the serotonin 2C receptor: comparisons among inbred mouse strains. Gene 382:39–46.
  • Enstero M, Daniel C, Wahlstedt H, Major F, Ohman M. 2009. Recognition and coupling of A-to-I edited sites are determined by the tertiary structure of the RNA. Nucleic Acids Res 37:6916–6926.
  • Ernst C, Mechawar N, Turecki G. 2009. Suicide neurobiology. Prog Neurobiol 89:315–333.
  • Esposito E. 2006. Serotonin-dopamine interaction as a focus of novel antidepressant drugs. Curr Drug Targets 7:177–185.
  • Fitzgerald LW, Iyer G, Conklin DS, Krause CM, Marshall A, Patterson JP, et al. 2005. Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology 21:82–90S.
  • Flomen R, Knight J, Sham P, Kerwin R, Makoff A. 2004. Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene. Nucleic Acids Res 32:2113–2122.
  • Gatch MB. 2003. Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety. Life Sci 73:1347–1367.
  • Gott JM, Emeson RB. 2000. Functions and mechanisms of RNA editing. Annu Rev Genet 34:499–531.
  • Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss C. 2002. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34:349–356.
  • Hartner JC, Schmittwolf C, Kispert A, Muller AM, Higuchi M, Seeburg PH. 2004. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 279:4894–4902.
  • Hawton K, Van Heeringen K. 2009. Suicide. Lancet 373: 1372–1381.
  • Herrick-Davis K, Grinde E, Niswender CM. 1999. Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction. J Neurochem 73:1711–1717.
  • Higuchi M, Maas S, Single FN, Hartner J, Rozov A, Burnashev N, et al. 2005. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406:78–81.
  • Iwamoto K, Kato T. 2003. RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci Lett 346:169–172.
  • Kenward MG, Roger JH. 1997. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53:983–997.
  • Lance CE (2005). Mallows’ Cp Statistics. In: Everitt BS, Howell DC, editors. Encyclopedia of statistics in behavioral science. Chichester: John Wiley & Sons. p. 1119–1120.
  • Mann JJ. 2003. Neurobiology of suicidal behaviour. Nat Rev Neurosci 4:819–828.
  • Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, et al. 2005. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57:729–738.
  • Mann JJ, Arango VA, Avenevoli S, Brent DA, Champagne FA, Clayton P, et al. 2005. Candidate endophenotypes for genetic studies of suicidal behavior. Biol Psychiatry 65:556–563.
  • Marion S, Weiner DM, Caron MG. 2004. RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2c receptor isoforms. J Biol Chem 279:2945–2954.
  • Millan MJ. 2005. Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. Therapie 60:441–460.
  • Morabito MV, Ulbricht RJ, O'Neil RT, Airey DC, Lu P, Zhang B, et al. 2005. High-throughput multiplexed transcript analysis yields enhanced resolution of 5-hydroxytryptamine 2C receptor mRNA editing profiles. Mol Pharmacol 77:895–902.
  • Moreno FA, Rowe DC, Kaiser B, Chase D, Michaels T, Gelernter J, et al. 2005. Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion. Mol Psychiatry 7:213–216.
  • Nishikura K. 2010. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 79:321–349.
  • Niswender CM, Copeland SC, Herrick-Davis K, Emeson RB, Sanders-Bush E. 1999. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem 274:9472–9478.
  • Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA, et al. 2005. RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 24:478–491.
  • Palvimaki EP, Roth BL, Majasuo H, Laakso A, Kuoppamaki M, Syvalahti E, et al. 1996. Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor. Psychopharmacology (Berlin) 126:234–240.
  • Pandey GN, Dwivedi Y, Ren X, Rizavi HS, Roberts RC, Conley RR. 2007. Cyclic AMP response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus. Int J Neuropsychopharmacol 10:621–629.
  • Quirk K, Lawrence A, Jones J, Misra A, Harvey V, Lamb H, et al. 2005. Characterisation of agonist binding on human 5-HT2C receptor isoforms. Eur J Pharmacol 419:107–112.
  • Serretti A, Artioli P, De Ronchi D. 2004. The 5-HT2C receptor as a target for mood disorders. Expert Opin Ther Targets 8: 15–23.
  • Simmons M, Meador-Woodruff JH, Sodhi MS. 2010. Increased cortical expression of an RNA editing enzyme occurs in major depressive suicide victims. NeuroReport 21:993–997.
  • Smith KA, Fairburn CG, Cowen PJ. 1997. Relapse of depression after rapid depletion of tryptophan. Lancet 349:915–919.
  • Sodhi MS, Airey DC, Lambert W, Burnet PW, Harrison PJ, Sanders-Bush E. 2005. A rapid new assay to detect RNA editing reveals antipsychotic-induced changes in serotonin-2C transcripts. Mol Pharmacol 68:711–719.
  • Tohda M, Hang PT, Kobayashi N, Matsumoto K. 2010. Serotonin 2C receptor (5-HT2CR) mRNA editing-induced down-regulation of 5-HT2CR function in Xenopus oocytes: the significance of site C editing. J Pharmacol Sci 113:362–367.
  • Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. 2000. The stanley foundation brain collection and neuropathology consortium 1. Schizophr Res 44:151–155.
  • Valente L, Nishikura K. 2005. ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation. Prog Nucleic Acid Res Mol Biol 79:299–338.
  • Vitali P, Basyuk E, Le Meur E, Bertrand E, Muscatelli F, Cavaille J, et al. 2005. ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs. J Cell Biol 169:745–753.
  • Wang Q, Khillan J, Gadue P, Nishikura K. 2000a. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290:1765–1768.
  • Wang Q, O'Brien PJ, Chen CX, Cho DS, Murray JM, Nishikura K. 2000b. Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. J Neurochem 74:1290–1300.
  • Werry TD, Loiacono R, Sexton PM, Christopoulos A. 2008. RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling pharmacology and brain function. Pharmacol Ther 119:7–23.
  • Yang W, Wang Q, Kanes SJ, Murray JM, Nishikura K. 2004. Altered RNA editing of serotonin 5-HT2C receptor induced by interferon: implications for depression associated with cytokine therapy. Brain Res Mol Brain Res 124:70–78.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.